Becker's Healthcare September 10, 2024
Rylee Wilson

Centene expects rising Medicaid expenses to hurt its third-quarter earnings.

In documents filed with the Securities and Exchange Commission Sept. 10, the insurer said it expects its third quarter earnings per share to decline by 20 to 30 cents. Those earnings will shift to the fourth quarter, Centene said.

The company is maintaining its full year earnings guidance of at least $6.80 per share.

At an investor presentation on Sept. 4, Centene CFO Drew Asher said the company expected medical expenses in Medicaid to be higher in the third quarter than in the second quarter.

Centene’s medical loss ratio in the second quarter of 2024 was 87.6%.

Mr. Asher said medicaid redeterminations were the main...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Insurance, Medicaid, Payer
Medicaid Expansion is a Red and Blue State Issue
Biden administration proposes Medicare coverage for weight loss drugs: 10 things to know
Proposed Coverage of Anti-Obesity Drugs in Medicare and Medicaid Would Expand Access to Millions of People with Obesity
Medicare and Medicaid would cover Ozempic, Wegovy under new Biden rule
New Proposal Aims to Expand Medicaid and Medicare Coverage for Obesity Drugs

Share This Article